| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/02/2002 | CN1371730A Powder medicine for treating cerebritis |
| 10/02/2002 | CN1371726A Decocted pill medicine for treating excess syndrome of hepatitis B |
| 10/02/2002 | CN1371725A Capsule for treating AIDS and tumor and preparation process thereof |
| 10/02/2002 | CN1371723A Anti-tumor and antiviral medicine and production method thereof |
| 10/02/2002 | CN1371716A Powder medicine for resolving phthisis and removing tuberculosis |
| 10/02/2002 | CN1371706A Aloes lozenge and preparation method thereof |
| 10/02/2002 | CN1371703A Ampelopsis grossedentata lozenge |
| 10/02/2002 | CN1371701A Antitetanic medicine and preparation method thereof |
| 10/02/2002 | CN1371691A Concentrated clear solution containing macrolides drug for intraveenous injection after being dilnted |
| 10/02/2002 | CN1371684A Novel biological activity of proglumide |
| 10/02/2002 | CN1371682A Compound zinc undecylenate ointment for treating beriberi |
| 10/02/2002 | CN1091770C Compounds useful as antiproliferative agents and GARFT inhibitors |
| 10/02/2002 | CN1091613C Ointment for preventing infection of external injury |
| 10/02/2002 | CN1091599C Anti-HIV triple combination |
| 10/02/2002 | CN1091596C Anti fungal agent, compound therefor, process for producing the same |
| 10/02/2002 | CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection |
| 10/01/2002 | US6458959 Anti-herpesvirus compounds and methods for identifying, making and using same |
| 10/01/2002 | US6458933 Specific for hla class ii invariant chain; side effect reduction of chemotherapy; drug clearance |
| 10/01/2002 | US6458925 Peptide antagonists of zonulin and methods for use of the same |
| 10/01/2002 | US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases |
| 10/01/2002 | US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer |
| 10/01/2002 | US6458810 Pharmaceutically active isoindoline derivatives |
| 10/01/2002 | US6458801 Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same |
| 10/01/2002 | US6458788 4-hydroxycinnoline-3-carboxyamides as antiviral agents |
| 10/01/2002 | US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated |
| 10/01/2002 | US6458785 Aids therapy |
| 10/01/2002 | US6458780 Carbapenem derivatives |
| 10/01/2002 | US6458776 Inflammatory bowel disease |
| 10/01/2002 | US6458773 Nucleoside with anti-hepatitis B virus activity |
| 10/01/2002 | US6458771 Series of ketolide antibacterials in the macrolide family, drugs and intermediates, erythromycin analogues useful in the treatment of bacterial and protozoal infections and in the treatment of gastric motility |
| 10/01/2002 | US6458766 A pharmaceutically acceptable salt or derivatives thereof, useful for preventing or treating viral and microbial infections, of oligopeotides |
| 10/01/2002 | US6458586 Replication of defective vectors with mutations and deletions; gene therapy, vaccines, genetic engineering |
| 10/01/2002 | US6458572 Phosphatidylglycerophosphate synthase from Staphylococcus aureus |
| 10/01/2002 | US6458527 Using synthetic or recombinant polypeptides as gag antigen; diagnosis of human immunodeficiency virus |
| 10/01/2002 | US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
| 10/01/2002 | US6458370 Use of microparticles combined with submicron oil-in-water emulsions |
| 10/01/2002 | US6458368 As vaccines for immunization |
| 10/01/2002 | US6458366 Compounds and methods for diagnosis of tuberculosis |
| 10/01/2002 | US6458364 Non-splicing variants of gp350/220 |
| 10/01/2002 | US6458363 Method to produce inactivated w/o emulsion adjuvated vaccines |
| 10/01/2002 | US6458362 Recombinant VP2 parvoviral pseudo-particles encoding CTL or T-helper cell epitopes |
| 10/01/2002 | US6458361 Soaking in water, heating beyond boiling point, stirring, filtering |
| 10/01/2002 | US6458353 Anti-CCR2 antibodies and methods of use therefor |
| 10/01/2002 | US6458346 Broad spectrum microbicidal and spermicidal compositions, devices, and methods |
| 10/01/2002 | US6458338 Amino acid stabilized medicinal aerosol formulations |
| 10/01/2002 | CA2245857C 1,4-dihydropyridine compounds as bradykinin antagonists |
| 10/01/2002 | CA2224460C Process for producing gm2 specific antibodies |
| 10/01/2002 | CA2168113C Therapeutic peptide derivatives |
| 10/01/2002 | CA2145411C Viscous liquid xylitol compositions and process for preparing the same |
| 10/01/2002 | CA2073031C Anti-cd4 antibody homologs useful in prophylaxis and treatment of aids, arc and hiv infection |
| 10/01/2002 | CA2065104C Erucyl, brassidyl and nervonyl derivatives |
| 09/28/2002 | CA2340455A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 09/26/2002 | WO2002075507A2 Anti-bacterial vaccine compositions |
| 09/26/2002 | WO2002074971A1 Flavonoid compound and process for producing the same |
| 09/26/2002 | WO2002074939A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells |
| 09/26/2002 | WO2002074913A2 Nucleic acid-associated proteins |
| 09/26/2002 | WO2002074910A2 Selective anti-viral nucleoside chain terminators |
| 09/26/2002 | WO2002074806A2 New interferon beta-like molecules |
| 09/26/2002 | WO2002074783A2 Modified interferon beta with reduced immunogenicity |
| 09/26/2002 | WO2002074777A2 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity |
| 09/26/2002 | WO2002074771A1 Tricyclic heterocyclic compound, process for producing the same, and use |
| 09/26/2002 | WO2002074769A1 Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient |
| 09/26/2002 | WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 09/26/2002 | WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 09/26/2002 | WO2002074743A1 Aryl-substituted alicyclic compound and medical composition comprising the same |
| 09/26/2002 | WO2002074742A2 Cdk-inhibitory indirubin derivatives having an increased solubility |
| 09/26/2002 | WO2002074730A1 INHIBITORS OF INTEGRIN αvβ¿6? |
| 09/26/2002 | WO2002074726A2 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| 09/26/2002 | WO2002074346A2 Targeting chemical compounds to cells |
| 09/26/2002 | WO2002074336A2 Influenza vaccine formulations for intradermal delivery |
| 09/26/2002 | WO2002074335A2 Equine herpesvirus vaccine |
| 09/26/2002 | WO2002074328A1 Methods of treating respiratory conditions |
| 09/26/2002 | WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders |
| 09/26/2002 | WO2002074313A1 Drugs containing reduced vitamin b¿2? |
| 09/26/2002 | WO2002074311A1 Antitumoral, antiviral, antibacterial, antiparasitic, anti-inflammatory, immunomodulatory and antimicotic medicinal preparation, method for production and dosage forms thereof |
| 09/26/2002 | WO2002074292A2 Hormone replacement therapy |
| 09/26/2002 | WO2002074287A2 Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics |
| 09/26/2002 | WO2002074246A2 Method and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds |
| 09/26/2002 | WO2002074156A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 09/26/2002 | WO2002074085A1 Neorustmicin a-derivatives |
| 09/26/2002 | WO2002062999A8 Proteins and nucleic acids encoding same |
| 09/26/2002 | WO2002056755A3 Method for treating cancer |
| 09/26/2002 | WO2002055517A3 4-(hetero)aryl substituted indolinones |
| 09/26/2002 | WO2002053581A3 Spliceosome mediated rna trans-splicing |
| 09/26/2002 | WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
| 09/26/2002 | WO2002032461A3 Protein c or activated protein c-like molecules |
| 09/26/2002 | WO2002032397A8 Electroprocessing in drug delivery and cell encapsulation |
| 09/26/2002 | WO2002024685A8 Indole derivatives and their use as antifungal and/or antiparasitic agents |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO2002024220A3 Vaccine comprising heat stress proteins from herbaceous plants |
| 09/26/2002 | WO2002000693A3 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 09/26/2002 | WO2001098332A3 Secreted redox proteins |
| 09/26/2002 | WO2001098317A3 Alpha-glycosylceramides for treating bacterial and fungal infections |
| 09/26/2002 | WO2001090159B1 Compositions and methods for delivery of a molecule into a cell |
| 09/26/2002 | WO2001090143A3 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 09/26/2002 | WO2001087343A3 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 09/26/2002 | WO2001083775A3 Proteases |
| 09/26/2002 | WO2001076568A3 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 09/26/2002 | WO2001072750A1 Novel crystal form of pyrrolidylthiocarbapenem derivative |
| 09/26/2002 | WO2001072743A1 Triazole compounds having amide linkage |